Paper39609491
Sanguinarine identified as a natural dual inhibitor of AURKA and CDK2 through network pharmacology and bioinformatics approaches.
Li X and 1 other. Sci Rep, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Sanguinarine identified as a natural dual inhibitor of AURKA and CDK2 through network pharmacology and bioinformatics approaches. Papers, record 39609491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39609491
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sanguinarine identified as a natural dual inhibitor of AURKA and CDK2 through network pharmacology and bioinformatics approaches.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzophenanthridines | Major topic |
| Isoquinolines | Major topic |
| Aurora Kinase A | Major topic |
| Cyclin-Dependent Kinase 2 | Major topic |
| Molecular Docking Simulation | Major topic |
| Computational Biology | Major topic |
| Humans | |
| Female | |
| Network Pharmacology | |
| Uterine Cervical Neoplasms | |
| Molecular Dynamics Simulation | |
| Protein Interaction Maps |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31163195 | p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. | Cancer Lett | 2019 | https://conductscience.org/library/papers/31163195 | PubMed |
| 2 | 10329703 | The Xenopus laevis aurora-related protein kinase pEg2 associates with and phosphorylates the kinesin-related protein XlEg5. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10329703 | PubMed |
| 3 | 37210578 | Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/37210578 | PubMed |
| 4 | 38215574 | Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma. | Phytomedicine | 2024 | https://conductscience.org/library/papers/38215574 | PubMed |
| 5 | 7720077 | Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. | Cell | 1995 | https://conductscience.org/library/papers/7720077 | PubMed |
| 6 | 38049204 | Bioinspired Lipoproteins of Furoxans-Gemcitabine Preferentially Targets Glioblastoma and Overcomes Radiotherapy Resistance. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38049204 | PubMed |
| 7 | 39344321 | Aurora A Kinase Begins to Localize to the Centrosome in the S-phase of the Cell Cycle in the XL2 Cell Line. | Front Biosci (Landmark Ed) | 2024 | https://conductscience.org/library/papers/39344321 | PubMed |
| 8 | 17145705 | BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. | Nucleic Acids Res | 2007 | https://conductscience.org/library/papers/17145705 | PubMed |
| 9 | 26879404 | BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. | Sci Rep | 2016 | https://conductscience.org/library/papers/26879404 | PubMed |
| 10 | 30371825 | PubChem 2019 update: improved access to chemical data. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371825 | PubMed |
| 11 | 35089821 | Nobiletin as a chemopreventive natural product against cancer, a comprehensive review. | Crit Rev Food Sci Nutr | 2023 | https://conductscience.org/library/papers/35089821 | PubMed |
| 12 | 26590256 | STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26590256 | PubMed |
| 13 | 34154613 | Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34154613 | PubMed |
| 14 | 25521941 | cytoHubba: identifying hub objects and sub-networks from complex interactome. | BMC Syst Biol | 2014 | https://conductscience.org/library/papers/25521941 | PubMed |
| 15 | 9454730 | The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. | J Cell Sci | 1998 | https://conductscience.org/library/papers/9454730 | PubMed |
| 16 | 12519968 | Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE. | Nucleic Acids Res | 2003 | https://conductscience.org/library/papers/12519968 | PubMed |
| 17 | 32278478 | A Review of Cervical Cancer: Incidence and Disparities. | J Natl Med Assoc | 2020 | https://conductscience.org/library/papers/32278478 | PubMed |
| 18 | 17287757 | Relating protein pharmacology by ligand chemistry. | Nat Biotechnol | 2007 | https://conductscience.org/library/papers/17287757 | PubMed |
| 19 | 12699628 | A novel mechanism for activation of the protein kinase Aurora A. | Curr Biol | 2003 | https://conductscience.org/library/papers/12699628 | PubMed |
| 20 | 38753784 | DNA damage induces p53-independent apoptosis through ribosome stalling. | Science | 2024 | https://conductscience.org/library/papers/38753784 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41226238 | Eight Triplex-Binding Molecules from Four Chemical Classes Broadly Recognize the MALAT1 Triple Helix. | Molecules | 2025 | https://conductscience.org/library/papers/41226238 | PubMed |
| 40076843 | Identification and Molecular Mechanism of Novel α-Glucosidase Inhibitory Peptides from the Hydrolysate of Hemp Seed Proteins: Peptidomic Analysis, Molecular Docking, and Dynamics Simulation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076843 | PubMed |
| 40018381 | Virtual perspectives of sanguinarine on cancer prevention and treatment through molecular dynamic study. | In Silico Pharmacol | 2025 | https://conductscience.org/library/papers/40018381 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AURKA | 6790 | PubTator's text mining | https://conductscience.org/library/genes/6790 | NCBI Gene |
| CDK2 | 1017 | PubTator's text mining | https://conductscience.org/library/genes/1017 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39609491
GET https://conductscience.org/api/papers/v1/39609491/references?page=2